PMID: 11929692Apr 4, 2002Paper

Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan

Diagnostic Microbiology and Infectious Disease
Jann-Tay WangShan-Chwen Chang

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has become an important nosocomial pathogen and has increased frequency in the past 20 years. It is highly transmissible between wards, hospitals, and cities. In most major hospitals in Taiwan, MRSA accounts for more than 60% of the S. aureus isolates. Whether there is a predominant strain, which is spread over the whole of Taiwan has not yet been studied. We collected 208 sequential clinical isolates of MRSA from 22 hospitals: seven in northern Taiwan, seven in western Taiwan, five in southern Taiwan, and three in eastern Taiwan during a three-month period in 1998. Using pulsed-field gel electrophoresis, 112 MRSA isolates were shown to belong to one major type,--type C, and this type was shown to have spread widely across all of Taiwan. Ninety-six isolates belonged to 20 other minor types. Most MRSA isolates of this major type were multi-drug resistant and only susceptible to vancomycin and rifampin. We concluded that the high prevalence of MRSA in Taiwan was partly due to the spreading of a predominant strain and most of them were multi-drug resistant. This might imply that more effort should be made to control the spread of MRSA in Taiwan.

References

Dec 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce
Sep 16, 1991·The American Journal of Medicine·S H CohenM Bradford
Dec 1, 1990·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce
Jan 1, 1987·The Journal of Hospital Infection·D E TownsendW B Grubb
May 1, 1988·The Journal of Hospital Infection·R R Marples, E M Cooke
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·G C Schito, P E Varaldo
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·B D Cookson, I Phillips
Sep 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M BoyceA A Medeiros
Jan 1, 1996·The Journal of Antimicrobial Chemotherapy·J PachonF Vaquero
Nov 1, 1996·The Journal of Hospital Infection·C WildemauweE Hannecart-Pokorni
Oct 6, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R S RomanL E Nicolle
Dec 16, 1997·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·F A Adeyemi-DoroA F Cheng
Jan 27, 1998·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Apr 4, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S SalmenlinnaJ Vuopio-Varkila
Jun 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Herminia de LencastreAlexander Tomasz
Oct 13, 2006·Current Opinion in Infectious Diseases·J Verhoef
Mar 1, 1997·International Journal of Antimicrobial Agents·S C ChangW C Hsieh

❮ Previous
Next ❯

Citations

Oct 16, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E S LestariUNKNOWN Antimicrobial Resistance in Indonesia: Prevalence and Prevention (AMRIN)
Nov 21, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N Abdel-HaqM Amjad
Sep 21, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S-Y ChenP-R Hsueh
Apr 15, 2004·International Journal of Antimicrobial Agents·L Clifford McDonaldUNKNOWN TSAR Participating Hospitals
Feb 13, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jiun-Ling WangShan-Chwen Chang
Jan 13, 2004·Journal of Clinical Microbiology·Yhu-Chering HuangTzou-Yien Lin
Aug 6, 2005·Journal of Clinical Microbiology·Jang-Jih LuAn-Hang Yang
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cheng-Hsin LinShu-Hsun Chu
Jan 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G C Schito
Feb 17, 2009·Diagnostic Microbiology and Infectious Disease·Wang-Huei ShengShan-Chwen Chang
Mar 15, 2011·International Journal of Antimicrobial Agents·Yhu-Chering Huang, Chih-Jung Chen
Aug 28, 2007·Veterinary Microbiology·Jui-Ming HsiehChin-Cheng Chou
Oct 5, 2010·Journal of Medical Microbiology·A ZafarK Bamford
Jan 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R Finch
Dec 17, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y-C HuangT-Y Lin
Sep 16, 2004·The American Journal of the Medical Sciences·Ron-Bin Hsu, Shu-Hsun Chu
Aug 12, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ron-Bin Hsu
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ron-Bin Hsu, Fang-Yue Lin
Aug 31, 2004·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A L R Z BerettaM L Moretti
Mar 17, 2011·Annals of Plastic Surgery·Nai-Chen ChengYueh-Bih Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Emerging Infectious Diseases
Feng-Jui ChenKeichii Hiramatsu
Emerging Infectious Diseases
Jann-Tay WangShan-Chwen Chang
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Ronan J MurrayGary D Lum
© 2022 Meta ULC. All rights reserved